Episodes where prescriptions for both moxifloxacin and levofloxacin were filled on the first day of the treatment episode. Episodes where another antibacterial used to treat uSSSIs was filled on ...
A literature search was conducted to evaluate the pharmacokinetic and pharmacodynamic profile of the respiratory fluoroquinolones (gemifloxacin, levofloxacin and moxifloxacin) and their efficacy ...
Moxifloxacin (as HCl) 400mg/250mL; soln for IV infusion; latex- and preservative-free. Moxifloxacin inhibits topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback